Drugs / BEN101
last change May 2023 re-read 2 minutes ago

BEN101

Developed for
cancer
Investigated by
Fudan University · RenJi Hospital · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Trials 1 · a red edge is where a trial was stopped

2024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT05831033 May 2023 → Feb 2027 expected cancer Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BEN101 ClinicalTrials.gov intervention name — accepted as the source's own label NCT05831033